Cryosite Ltd

CTE

Company Profile

  • Business description

    Cryosite Ltd provides an integrated clinical trial logistics service, biological storage and sample management service, including the storage of cord blood stem cells for private use. It supports a diverse portfolio of materials, including Good Manufacturing Practice (GMP) clinical trial products, Australian Register of Therapeutic Goods (ARTG) approved medicines, biologics, Research and Development materials, and medical devices, among others. The group's operating segments are: Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord blood. The majority of its revenue is generated from the Ambient, cold, and frozen segment, which provides storage and distribution of small-molecule drugs and related products requiring ambient, refrigerated, or frozen conditions.

  • Contact

    13a Ferndell Street
    South Granville
    SydneyNSW2142
    AUS

    T: +61 288652000

    https://www.cryosite.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 June 2026

    Employees

    25

Stocks News & Analysis

stocks

Perplexing buyback from overvalued ASX share

Earnings continue to grow but investor expectations are too high.
stocks

Most popular shares in SMSFs

With data showing the continued rise of SMSFs, we explore the top stock picks of individual investors
stocks

Will China strong arm BHP into lower iron ore prices?

Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,188.6028.90-0.31%
CAC 407,934.2616.260.21%
DAX 4024,387.93146.470.60%
Dow JONES (US)46,067.58587.981.29%
FTSE 1009,442.8715.400.16%
HKSE25,889.48400.84-1.52%
NASDAQ22,694.61490.182.21%
Nikkei 22547,557.11531.69-1.11%
NZX 50 Index13,248.27103.65-0.78%
S&P 5006,654.72102.211.56%
S&P/ASX 2008,877.8031.90-0.36%
SSE Composite Index3,889.470.03-0.00%

Market Movers